{"id":"https://openalex.org/W2947282900","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.3000","title":"Belvarafenib, a novel pan-RAF inhibitor, in solid tumor patients harboring BRAF, KRAS, or NRAS mutations: Phase I study.","display_name":"Belvarafenib, a novel pan-RAF inhibitor, in solid tumor patients harboring BRAF, KRAS, or NRAS mutations: Phase I study.","publication_year":2019,"publication_date":"2019-05-20","ids":{"openalex":"https://openalex.org/W2947282900","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.3000","mag":"2947282900"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.15_suppl.3000","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.3000","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.3000","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101425291","display_name":"Tae Won Kim","orcid":"https://orcid.org/0000-0001-9522-1997","observed_orcids":["https://orcid.org/0000-0001-9522-1997"]},"institutions":[{"id":"https://openalex.org/I2801680663","display_name":"Asan Medical Center","ror":"https://ror.org/03s5q0090","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801680663","https://openalex.org/I4210167194"]},{"id":"https://openalex.org/I40542001","display_name":"University of Ulsan","ror":"https://ror.org/02c2f8975","country_code":"KR","type":"education","lineage":["https://openalex.org/I40542001"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Tae Won Kim","raw_affiliation_strings":["Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea;","institution_ids":["https://openalex.org/I2801680663","https://openalex.org/I40542001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019406140","display_name":"Jeeyun Lee","orcid":"https://orcid.org/0000-0002-4911-6165","observed_orcids":["https://orcid.org/0000-0002-4911-6165"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jeeyun Lee","raw_affiliation_strings":["Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051983148","display_name":"Sang Joon Shin","orcid":"https://orcid.org/0000-0001-5350-7241","observed_orcids":["https://orcid.org/0000-0001-5350-7241"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210160791","display_name":"Yonsei University Health System","ror":"https://ror.org/04sze3c15","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Sang Joon Shin","raw_affiliation_strings":["Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea;","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100390280","display_name":"Jin-Soo Kim","orcid":"https://orcid.org/0000-0003-2636-2352","observed_orcids":["https://orcid.org/0000-0003-2636-2352"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]},{"id":"https://openalex.org/I4210100437","display_name":"SNUH SMG-SNU Boramae Medical Center","ror":"https://ror.org/014xqzt56","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388","https://openalex.org/I4210100437"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jin-Soo Kim","raw_affiliation_strings":["Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, South Korea;","institution_ids":["https://openalex.org/I139264467","https://openalex.org/I4210100437"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044075250","display_name":"Yu Jung Kim","orcid":"https://orcid.org/0000-0002-5037-0523","observed_orcids":["https://orcid.org/0000-0002-5037-0523"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]},{"id":"https://openalex.org/I2803058125","display_name":"Seoul National University Bundang Hospital","ror":"https://ror.org/00cb3km46","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388","https://openalex.org/I2803058125"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Yu Jung Kim","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea;","institution_ids":["https://openalex.org/I139264467","https://openalex.org/I2803058125"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076196426","display_name":"Hye Sook Han","orcid":"https://orcid.org/0000-0001-6729-8700","observed_orcids":["https://orcid.org/0000-0001-6729-8700"]},"institutions":[{"id":"https://openalex.org/I163753206","display_name":"Chungbuk National University","ror":"https://ror.org/02wnxgj78","country_code":"KR","type":"education","lineage":["https://openalex.org/I163753206"]},{"id":"https://openalex.org/I4210161026","display_name":"Chungbuk National University Hospital","ror":"https://ror.org/05529q263","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I163753206","https://openalex.org/I4210161026"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Hye Sook Han","raw_affiliation_strings":["Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, South Korea;","institution_ids":["https://openalex.org/I163753206","https://openalex.org/I4210161026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084299599","display_name":"Soo Jung Lee","orcid":"https://orcid.org/0000-0003-0066-4109","observed_orcids":["https://orcid.org/0000-0003-0066-4109","https://orcid.org/0000-0002-0139-9768"]},"institutions":[{"id":"https://openalex.org/I31419693","display_name":"Kyungpook National University","ror":"https://ror.org/040c17130","country_code":"KR","type":"education","lineage":["https://openalex.org/I31419693"]},{"id":"https://openalex.org/I4405258372","display_name":"Kyungpook National University Chilgok Hospital","ror":"https://ror.org/00hyr5m88","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801673063","https://openalex.org/I31419693","https://openalex.org/I4405258372"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Soo Jung Lee","raw_affiliation_strings":["Department of Oncology/Hematology, Kyungpook National University Chilgok Hospital, Kyungpook National University, Daegu, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology/Hematology, Kyungpook National University Chilgok Hospital, Kyungpook National University, Daegu, South Korea;","institution_ids":["https://openalex.org/I31419693","https://openalex.org/I4405258372"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022631166","display_name":"Hyeong\u2010Seok Lim","orcid":"https://orcid.org/0000-0003-1420-8200","observed_orcids":["https://orcid.org/0000-0003-1420-8200"]},"institutions":[{"id":"https://openalex.org/I2801680663","display_name":"Asan Medical Center","ror":"https://ror.org/03s5q0090","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801680663","https://openalex.org/I4210167194"]},{"id":"https://openalex.org/I40542001","display_name":"University of Ulsan","ror":"https://ror.org/02c2f8975","country_code":"KR","type":"education","lineage":["https://openalex.org/I40542001"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Hyeong-Seok Lim","raw_affiliation_strings":["Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea;","institution_ids":["https://openalex.org/I2801680663","https://openalex.org/I40542001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002569209","display_name":"Yoon-Hee Hong","orcid":"https://orcid.org/0000-0002-8224-4396","observed_orcids":["https://orcid.org/0000-0002-8224-4396"]},"institutions":[{"id":"https://openalex.org/I4210100154","display_name":"Hanmi Pharmaceutical (South Korea)","ror":"https://ror.org/013x1pp52","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210100154"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Yoon-hee Hong","raw_affiliation_strings":["Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea;","institution_ids":["https://openalex.org/I4210100154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082149375","display_name":"Young Su Noh","orcid":"https://orcid.org/0000-0002-4204-2503","observed_orcids":["https://orcid.org/0000-0002-4204-2503"]},"institutions":[{"id":"https://openalex.org/I35928602","display_name":"Kyung Hee University","ror":"https://ror.org/01zqcg218","country_code":"KR","type":"education","lineage":["https://openalex.org/I35928602"]},{"id":"https://openalex.org/I4210100154","display_name":"Hanmi Pharmaceutical (South Korea)","ror":"https://ror.org/013x1pp52","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210100154"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Young Su Noh","raw_affiliation_strings":["Hanmi Pharmaceutical Co., Ltd., Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hanmi Pharmaceutical Co., Ltd., Department of Pharmaceutical Biochemistry, College of Pharmacy, Kyung Hee University, Seoul, South Korea;","institution_ids":["https://openalex.org/I35928602","https://openalex.org/I4210100154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022389918","display_name":"YU-JUNG KYOUNG","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100154","display_name":"Hanmi Pharmaceutical (South Korea)","ror":"https://ror.org/013x1pp52","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210100154"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Yujung Kyoung","raw_affiliation_strings":["Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea;","institution_ids":["https://openalex.org/I4210100154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053897485","display_name":"Oakpil Han","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100154","display_name":"Hanmi Pharmaceutical (South Korea)","ror":"https://ror.org/013x1pp52","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210100154"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Oakpil Han","raw_affiliation_strings":["Hanmi Pharm. Co., Ltd., Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hanmi Pharm. Co., Ltd., Seoul, South Korea;","institution_ids":["https://openalex.org/I4210100154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052102554","display_name":"Jiyeon Yoon","orcid":"https://orcid.org/0000-0002-8005-8100","observed_orcids":["https://orcid.org/0000-0002-8005-8100"]},"institutions":[{"id":"https://openalex.org/I4210100154","display_name":"Hanmi Pharmaceutical (South Korea)","ror":"https://ror.org/013x1pp52","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210100154"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jiyeon Yoon","raw_affiliation_strings":["Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea;","institution_ids":["https://openalex.org/I4210100154"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102691594","display_name":"Jeong Ah Lim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100154","display_name":"Hanmi Pharmaceutical (South Korea)","ror":"https://ror.org/013x1pp52","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210100154"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jeong Ah Lim","raw_affiliation_strings":["Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea;","institution_ids":["https://openalex.org/I4210100154"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086968027","display_name":"Suk Ran Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100154","display_name":"Hanmi Pharmaceutical (South Korea)","ror":"https://ror.org/013x1pp52","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210100154"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Suk Ran Kim","raw_affiliation_strings":["Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea;","institution_ids":["https://openalex.org/I4210100154"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":15,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"15_suppl","first_page":"3000","last_page":"3000"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ras-mutations","display_name":"RAS mutations","score":0.7250000238418579},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.9559999704360962},{"id":"https://openalex.org/keywords/nras-mutation","display_name":"NRAS mutation","score":0.8600000143051147},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.746999979019165},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7139999866485596},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8370000123977661},{"id":"https://openalex.org/keywords/recommended-dose","display_name":"recommended dose","score":0.640999972820282},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6050000190734863},{"id":"https://openalex.org/keywords/gastrointestinal-stromal-tumor","display_name":"gastrointestinal stromal tumor","score":0.8759999871253967},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.890999972820282},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7260000109672546},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.6890000104904175},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.5789999961853027},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.6290000081062317},{"id":"https://openalex.org/keywords/basket-trials","display_name":"basket trials","score":0.3400000035762787},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.32499998807907104},{"id":"https://openalex.org/keywords/dermatologic-adverse-events","display_name":"dermatologic adverse events","score":0.44600000977516174}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9236270189285278},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.7277894020080566},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.7118205428123474},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7001194953918457},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.6248735785484314},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6126552820205688},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5801880359649658},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4957815110683441},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.48960548639297485},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4806588888168335},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.45131468772888184},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34438616037368774},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.24612560868263245}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.15_suppl.3000","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.3000","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.3000","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3172449441","https://openalex.org/W3201664574","https://openalex.org/W3182386187","https://openalex.org/W3157426342","https://openalex.org/W2519708248","https://openalex.org/W4387811499","https://openalex.org/W3181752575","https://openalex.org/W4391446706","https://openalex.org/W7124446186","https://openalex.org/W3011687118"],"abstract_inverted_index":{"3000":[0],"Background:":[1],"Belvarafenib":[2,75,302,335,354],"(HM95573/GDC-5573)":[3],"is":[4,355],"an":[5],"oral":[6],"type":[7,127],"II":[8],"pan-RAF":[9],"kinase":[10],"inhibitor":[11,364],"which":[12],"demonstrates":[13],"selective":[14],"anti-tumor":[15,149,341],"activity":[16,150,342],"in":[17,23,165,178,194,262,291,320,343,359],"several":[18],"non-clinical":[19],"cancer":[20,24],"models":[21],"and":[22,36,48,93,95,109,130,136,154,204,217,235,269,294,329,339],"patients":[25,71,137,164,199,275,290,321,344],"with":[26,54,74,276,298,322,345,361],"RAS-":[27,60,131],"or":[28,61,132,351],"RAF-":[29,62],"mutation.":[30],"Here":[31],"we":[32],"present":[33],"overall":[34],"safety":[35,92,311],"efficacy":[37],"findings":[38],"of":[39,45,80,121,128,141,171,198,208,213,273,305],"two":[40,317],"phase":[41],"1":[42],"studies,":[43],"consisting":[44],"dose":[46,49,68,79,99,116,159,167,285],"escalation":[47,69,102,160],"expansion":[50,117,286],"stages.":[51],"Methods:":[52],"Patients":[53],"advanced":[55,346],"solid":[56,347],"cancers":[57],"harboring":[58,349],"documented":[59],"mutation":[63],"were":[64,72,200,215,247,316],"enrolled.":[65],"In":[66],"the":[67,97,126,139,222,233,242,362],"study,":[70],"treated":[73],"at":[76,221],"a":[77,111,280],"starting":[78],"50":[81],"mg":[82,88,184,224,229,237,256,260,300],"once":[83],"daily":[84],"(QD)":[85],"to":[86,90,125,147,182,258],"800":[87,223,259],"BID":[89,225,230,238,261,301],"assess":[91],"tolerability":[94],"identify":[96],"recommended":[98],"(RD).":[100],"Dose":[101,175],"was":[103,119,146,231,239,313,336],"guided":[104],"based":[105],"on":[106],"pharmacokinetic":[107],"data":[108],"used":[110],"traditional":[112],"3+3":[113],"design.":[114],"The":[115,143,158,186,284],"study":[118,161,287],"comprised":[120],"6":[122,306],"cohorts":[123,168,296],"(according":[124],"tumor":[129],"RAF":[133,352],"gene":[134],"mutation)":[135],"received":[138],"RD":[140,243],"Belvarafenib.":[142,245],"primary":[144],"objective":[145],"explore":[148],"(per":[151],"RECIST":[152],"1.1)":[153],"pharmacodynamic":[155],"effects.":[156],"Results:":[157],"included":[162,218,288],"72":[163],"9":[166],"(cut-off":[169,303],"date":[170,304],"18":[172],"Jan":[173],"2017).":[174],"dependent":[176],"increase":[177],"exposures":[179],"observed":[180],"up":[181],"650":[183,228],"BID.":[185],"most":[187],"common":[188],"treatment-emergent":[189],"adverse":[190],"events":[191],"that":[192],"occurred":[193],"more":[195],"than":[196],"20%":[197],"rash,":[201],"dermatitis":[202],"acneiform":[203],"pyrexia.":[205],"A":[206],"total":[207],"4":[209],"DLTs":[210,220],"(different":[211],"kinds":[212],"rashes)":[214],"reported":[216],"2":[219],"level.":[226],"Therefore,":[227],"considered":[232],"MTD":[234],"450":[236,299],"identified":[240],"as":[241],"for":[244],"There":[246,315],"7":[248],"partial":[249],"responses":[250],"(3":[251],"confirmed":[252],"PRs)":[253],"from":[254],"200":[255],"QD":[257],"NRAS-mutant":[263,277,323],"melanoma,":[264,266],"BRAF-mutant":[265,270,326,330],"KRAS-mutant":[267],"sarcoma,":[268],"GIST.":[271],"Four":[272],"nine":[274],"melanoma":[278,324,327],"had":[279],"PR":[281],"(ORR":[282],"44%).":[283],"63":[289],"5":[292],"indication-specific":[293],"basket":[295],"administered":[297],"Oct":[307],"2018).":[308],"No":[309],"new":[310],"signal":[312],"detected.":[314],"PRs":[318],"each":[319],"(2/9),":[325],"(2/6)":[328],"CRC":[331],"(2/7),":[332],"respectively.":[333],"Conclusions:":[334],"well":[337],"tolerated":[338],"exhibited":[340],"tumors":[348],"RAS":[350],"mutations.":[353],"being":[356],"further":[357],"investigated":[358],"combination":[360],"MEK":[363],"cobimetinib.":[365],"Clinical":[366],"trial":[367],"information:":[368],"NCT02405065,":[369],"NCT03118817.":[370]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-06-07T00:00:00"}